References
[1] Dondapati M, Reyes J, Ahmad S, et al. Rare Adult Subtype of Rhabdomyosarcoma, a Common Childhood Soft Tissue Carcinoma. J Investig Med High Impact Case Rep 2021; 9: 23247096211042236.
[2] Ciammella P, Galeandro M, D’Abbiero N, et al. Prostate embryonal rhabdomyosarcoma in adults: Case report and review of literature.Rep Pract Oncol Radiother 2013: 18 (5), 310-315.
[3] Bleyer A, O’Leary M, Barr R and Ries L. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival 1975-2000. National Cancer Institute 2006; 06: 5767.
[4[ Stacchiotti S. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer 2021; 127 (16): 2934-2942.
[5] Amer K and Thromson J. Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis. J Orthop Res 2019; 37 (10): 2226-2230.
[6] Parham D and Barr F. Classification of rhabdomyosarcoma and its molecular basis . Adv Anat Pathol 2013; 20 (6): 387-397.
[7] Sultan I, Qaddoumi I, Yaser S, et al. Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients. J Clin Oncol 2009; 27 (20): 3391-3397.
[8] Crist W, Anderson J, Meza J, at al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19 (12): 3091-3102.
[9] Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution . Cancer 2003; 98 (3): 571-580.
[10] Kenney L, Grant F and Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood . Cancer 2001; 91 (3): 613-621.
[11] Makimoto A. Optimizing Rhabdomyosarcoma Treatment in Adolescents and Young Adults. Cancers 2022; 14 (9): 2270.
[12] Egas-bejar D and Huh W. Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. Adolesc 2014; 5 : 115-125.